KIMBERLY CLARK CORP
$100.85
+0.01%
Kimberly-Clark announced the acquisition of Kenvue in a deal valued at approximately $48.7 billion in enterprise value, creating a combined consumer goods and personal care leader, while also declaring its 54th consecutive annual dividend increase to $1.28 per share quarterly. Analyst consensus holds a Hold rating as investors await deal clarity and the strategic rationale for combining with Kenvue's consumer health portfolio. Risks include significant leverage from financing the large acquisition, regulatory approval requirements, and potential integration challenges across two large multi-brand consumer companies.